Global Medical Transdermal Patch Market Growth 2023-2029

Global Medical Transdermal Patch Market Growth 2023-2029

A transdermal patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. An advantage of a transdermal drug delivery route over other types of medication delivery (such as oral, topical, intravenous, or intramuscular) is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive. The main disadvantage to transdermal delivery systems stems from the fact that the skin is a very effective barrier; as a result, only medications whose molecules are small enough to penetrate the skin can be delivered by this method.

LPI (LP Information)' newest research report, the “Medical Transdermal Patch Industry Forecast” looks at past sales and reviews total world Medical Transdermal Patch sales in 2022, providing a comprehensive analysis by region and market sector of projected Medical Transdermal Patch sales for 2023 through 2029. With Medical Transdermal Patch sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical Transdermal Patch industry.

This Insight Report provides a comprehensive analysis of the global Medical Transdermal Patch landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medical Transdermal Patch portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Medical Transdermal Patch market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical Transdermal Patch and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical Transdermal Patch.

The global Medical Transdermal Patch market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Medical Transdermal Patch is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Medical Transdermal Patch is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Medical Transdermal Patch is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Medical Transdermal Patch players cover Hisamitsu Pharmaceutical, Johnson & Johnson, Novartis, UCB Pharma, Mylan, Teva Pharmaceutical, Nitto Denko, Grünenthal and IBSA Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Medical Transdermal Patch market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Methyl Salicylate-based Patch
Rivastigmine Transdermal Patch
Fentanyl Transdermal Patch
Lidocaine Patch
Diclofenac Patch
Nicotine Transdermal Patch
Others

Segmentation by application
Hospital
Clinic

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Hisamitsu Pharmaceutical
Johnson & Johnson
Novartis
UCB Pharma
Mylan
Teva Pharmaceutical
Nitto Denko
Grünenthal
IBSA Group
GSK
Luye Pharma Group
Pfizer
Chattem
Dr Reddy’s Laboratories
Bayer
Mundipharma
Endo International
Beijing Tide Pharmaceutical
Patch Export, LLC

Key Questions Addressed in this Report

What is the 10-year outlook for the global Medical Transdermal Patch market?

What factors are driving Medical Transdermal Patch market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Medical Transdermal Patch market opportunities vary by end market size?

How does Medical Transdermal Patch break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.